Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Repository of the University of Ljubljana
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Advanced
New in RUL
About RUL
In numbers
Help
Sign in
Details
Dual inhibitors of p38α mitogen-activated protein kinase and butyrylcholinesterase for the modulation of neuroinflammation and cognitive dysfunction
ID
Knez, Damijan
(
Author
),
ID
Meden, Anže
(
Author
),
ID
Ferjančič Benetik, Svit
(
Author
),
ID
Pišlar, Anja
(
Author
),
ID
Musílek, Kamil
(
Author
),
ID
Gobec, Stanislav
(
Author
), et al.
PDF - Presentation file,
Download
(7,24 MB)
MD5: 5EEE376E13134C1AE0F8B5E0B9DD7AB6
URL - Source URL, Visit
https://pubs.acs.org/jmcmar/article/69/16/19891/5251523/Dual-Inhibitors-of-p38-Mitogen-Activated-Protein
Image galllery
Abstract
Chronic neuroinflammation and cholinergic dysfunction are major contributors to cognitive decline in Alzheimer’s disease. Here, we report a series of pyridazine-based multitarget-directed ligands that simultaneously inhibit human butyrylcholinesterase (hBChE) and p38α mitogen-activated protein kinase (p38α MAPK). Pyridazines 8 and 21 were identified as potent dual inhibitors with submicromolar inhibitory potencies against target enzymes and high selectivity over acetylcholinesterase. X-ray crystallographic analyses revealed the experimental binding modes of 8 and 21 in hBChE and p38α MAPK, and identified conserved π–π, π–cation, and hinge region interactions that rationalize dual-target engagement. Both compounds were blood-brain barrier permeable, exhibited low cytotoxicity, and significantly attenuated lipopolysaccharide-induced proinflammatory responses and apoptosis in BV2 microglia. In vivo, compound 21 enhanced cognitive performance in mouse models of scopolamine-induced amnesia and LPS-stimulated neuroinflammatory cognitive impairment. Collectively, these results document the potential of structure-assisted design to achieve selective dual-target pharmacology within a single molecular entity.
Language:
English
Keywords:
inflammation
,
inhibitors
,
peptides and proteins
,
nervous system diseases
,
rodent models
Work type:
Article
Typology:
1.01 - Original Scientific Article
Organization:
FFA - Faculty of Pharmacy
Publication status:
Published
Publication version:
Version of Record
Year:
2026
Number of pages:
Str. 19891-19917
Numbering:
Vol. 69, iss. 16
PID:
20.500.12556/RUL-189714
UDC:
615.2-021.321:616.894
ISSN on article:
1520-4804
DOI:
10.1021/acs.jmedchem.6c01461
COBISS.SI-ID:
289183747
Publication date in RUL:
13.10.2026
Views:
75
Downloads:
35
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Copy citation
Share:
Record is a part of a journal
Title:
Journal of medicinal chemistry
Shortened title:
J. med. chem.
Publisher:
American Chemical Society
ISSN:
1520-4804
COBISS.SI-ID:
512806681
Licences
License:
CC BY 4.0, Creative Commons Attribution 4.0 International
Link:
http://creativecommons.org/licenses/by/4.0/
Description:
This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Secondary language
Language:
Slovenian
Keywords:
zaviralci vnetja
,
peptidi in beljakovine
,
bolezni živčnega sistema
,
modeli glodalcev
,
Alzheimerjeva bolezen
,
tarčna zdravila
Projects
Funder:
NCN - National Science Centre
Project number:
DEC-2021/43/I/NZ7/00342
Funder:
GAČR - Czech Science Foundation
Project number:
GF23-42701L
Funder:
ARIS - Slovenian Research and Innovation Agency
Project number:
N1-0277
Name:
Raziskave multifunkcionalnih spojin, usmerjenih proti nevroinflamaciji in holinergičnemu pomanjkanju pri Alzheimerjevi bolezni
Funder:
ARIS - Slovenian Research and Innovation Agency
Project number:
P1-0208
Name:
Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin
Funder:
ARIS - Slovenian Research and Innovation Agency
Project number:
P4-0127
Name:
Farmacevtska biotehnologija: znanost za zdravje
Funder:
ARIS - Slovenian Research and Innovation Agency
Funding programme:
Young researchers
Funder:
ARIS - Slovenian Research and Innovation Agency
Project number:
BI-FR/23-24-PROTEUS-002
Name:
Razvoj učinkovitih reaktivatorjev z organofosfati zavrte butirilholin esteraze
Funder:
ARIS - Slovenian Research and Innovation Agency
Funding programme:
University of Ljubljana, Great Interdisciplinary Project
Funder:
University of Hradec Kralove, Faculty of Science
Funding programme:
Excellence project
Project number:
2206/2025-2026
Funder:
MH CZ - Czech Republic
Funding programme:
DRO
Project number:
00179906
Acronym:
UHHK
Funder:
French Ministry of Armed Forces
Project number:
NBC-5-C-2316
Funder:
Jagiellonian University, Medical College
Funding programme:
Statutory funds
Project number:
N42/DBS/000454
Funder:
MIZŠ - Ministry of Education, Science, and Sport
Project number:
OP20.05187
Acronym:
RI-SI-EATRIS
Funder:
EC - European Commission
Funding programme:
European Regional Development Fund
Acronym:
RI-SI-EATRIS
Funder:
NIH - National Institutes of Health
Project number:
AG062095
Funder:
NIH - National Institutes of Health
Project number:
AG043415
Similar documents
Similar works from RUL:
Similar works from other Slovenian collections:
Back